Skip to content

039200.KQ

Oscotec Inc.

KOE · Healthcare · Drug Manufacturers - General · KR

KRW 35,900.00
−1.91%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue144.2B99.8B34.0B5.0B5.1B
Cost of Revenue2.7B1.9B2.2B2.0B3.5B
Gross Profit141.5B97.9B31.8B2.7B1.6B
Operating Expenses
R&D Expense30.6B27.6B21.4B24.9B23.3B
SG&A Expense11.6B7.5B4.4B8.5B6.2B
General & Admin Expense3.9B2.1B1.6B2.2B1.6B
Selling & Marketing Expense7.7B5.3B2.8B1.7B1.1B
Other Expenses19.5B10.7B8.6B6.8B5.5B
Total Operating Expenses51.7B45.8B34.5B33.4B29.6B
Cost and Expenses54.5B47.8B36.7B37.6B33.6B
Operating Income (EBIT)89.7B52.1B(2.7B)(32.7B)(28.5B)
Non-Operating
Interest Income4.6B3.9B4.0B4.8B1.2B
Interest Expense2.6B2.3B1.1B406.6M316.4M
Net Interest Income2.0B1.7B2.9B4.4B904.0M
Other Non-Op Income/Expense9.1B706.0M1.6B371.8M532.8M
Non-Operating Income (excl Interest)(3.1B)(3.0B)(2.7B)1.2B(849.2M)
EBT (Pre-Tax Income)98.8B52.8B(1.1B)(32.3B)(28.0B)
Income Tax Expense(1.6B)(1.6B)471.9M(3.8B)(209.3M)
Bottom Line
Net Income94.3B52.6B876.5M(24.3B)(24.4B)
Earnings from Cont. Ops100.4B54.4B(1.6B)(28.5B)(27.8B)
Earnings from Discont. Ops
Bottom Line Net Income94.3B52.6B876.5M(24.3B)(24.4B)
Per Share
Basic EPS₩2,464₩1,368₩23(₩635)(₩763)
Diluted EPS₩2,464₩1,368₩23(₩635)(₩763)
Revenue Per Share₩3,769₩2,610₩889₩129₩158
Shares
Basic Shares Outstanding38.3M38.3M38.2M38.2M32.0M
Diluted Shares Outstanding38.3M38.3M38.2M38.2M32.0M
Profitability Metrics
EBITDA92.5B53.7B1.9B(30.0B)(26.0B)
D&A1.4B1.5B1.9B1.9B1.6B
EBIT91.4B55.1B(32.5M)(31.9B)(27.7B)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026